Healthcare & Medical
Category / Healthcare & Medical
Shenzhen: SHENZHEN, Apr 23, 2026 - (ACN Newswire) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Alle ...
Hong Kong: HONG KONG, Apr 22, 2026 - (ACN Newswire) - Hengrui Pharma reported steady growth in the first quarter of 2026. In Q1 2026, the Company recorded revenue of RMB 8.14 billion, up 12.98% year-over-year, w ...
Hong Kong: - Demonstrating a Favorable Safety Profile, Robust Immunogenicity, and Promising Preliminary Efficacy ...
HONG KONG: HONG KONG, Apr 2, 2026 - (ACN Newswire) - Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a com ...
TORONTO, ON: Toronto, ON, Mar 25, 2026 - (ACN Newswire) - Aleen Inc. (CSE: ALEN-U), a digital wellness company, has introduced a new data layer within its Personal Wellness Account, designed to enhance how its AI ...
HONG KONG: HONG KONG, Mar 23, 2026 - (ACN Newswire) – Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited (“CORXEL”). Under ...
Toronto, ON: Toronto, ON, March 18, 2026 (ACN Newswire) - Aleen Inc. (CSE: ALEN-U), a digital wellness company, is currently exploring data standardization approaches that may support the continued development of ...
HONG KONG: HONG KONG, March 11, 2026 - (ACN Newswire) – March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the i ...
TOKYO: International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window
...
TOKYO: OMRON Healthcare releases new Women's Heart Health Factbook highlighting global hypertension care gap and life-stage risk factors ...
HONG KONG: HONG KONG, Feb 25, 2026 - (ACN Newswire) – Everest Medicines shareholders passed all proposed resolutions at an extraordinary general meeting (the “EGM”) held virtually on February 24, 2026, the ...
BOSTON, MA,: Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus ...
BOSTON, MA,: BOSTON, MA, Feb 17, 2026 - (ACN Newswire) - Bioxytran, Inc. (OTCMKTS: BIXT) (“Bioxytran” or the “Company”), a biotechnology company developing galectin-targeting carbohydrate technologies with ...
Boston: BOSTON, Feb 11, 2026 - (ACN Newswire) - Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-o ...
HONG KONG: HONG KONG, Feb 6, 2026 - (ACN Newswire) – Everest Medicines today announced that China's National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) f ...
TOKYO: Expanding production capacity by introducing automated equipment reduces manufacturing costs and shortens delivery times ...
HONG KONG: Shanghai, January 5, 2026 - (ACN Newswire) – Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical develop ...
TOKYO: Cloud-based AI application for colorectal cancer prevention: Enhancing detection of clinically significant lesions without compromising safety and workflow efficiency ...
